|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
TheraGenetics to Present at First Annual Boston Biotech R&D Conference
10/20/2008 10:09:15 AM
CAMBRIDGE, Mass. & LONDON--(BUSINESS WIRE)--TheraGenetics Limited, a personalized medicine diagnostics company that is developing and commercializing a portfolio of pharmacogenetic diagnostic tests to guide and improve the treatment of central nervous system (CNS) disorders, announced today that Richard Kivel, Chief Executive Officer of TheraGenetics will present at the 2008 Boston Biotech R&D Conference, at 1:00 p.m. (ET) on October 22, 2008 at Harvard Medical School in Boston, Massachusetts. TheraGenetics’ presentation will be moderated by Mike King of Rodman & Renshaw and will provide an overview of the company and its development efforts to bring personalized medicine diagnostics into clinical practice for patients living with diseases of the central nervous system, including schizophrenia, depression, bipolar disorder, Alzheimer's disease and ADHD (attention deficit hyperactivity disorder), through the use of pharmacogenetic tests.
|
|
|
|
|
|
|
|
|
|
|